Funding Opportunity

This award provides seed funding to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapie

The aim is to address clinically relevant questions about ketones and the use of CKM in T1D.

The purpose of this Notice of Funding Opportunity (NOFO) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Development Research Center. This NOFO also allows the inclusion of translational studies to facilitate the pre- clinical to clinical transition and increase the likelihood of clinical success.

This call supports projects that robustly test the real-world effectiveness and assess implementation strategies of scalable transformative early interventions for anxiety, depression and psychosis in young people.

The purpose of this NOFO is to solicit research applications focused on preclinical development of lead candidate vaccines to prevent Mycobacterium tuberculosis infection and/or disease, and to increase the clinical pipeline of viable vaccine candidates.

This RFA is intended to solicit proposals investigating the effects of insulin dose and insulin dose reduction on acute and long-term T1D outcomes.

The World Cancer Research Fund International invites applications for its regular grant programme. The aim of the WCRF Regular Grant Programme is to support innovative and original research into the role of diet, nutrition and physical activity in either Cancer Prevention or Cancer Survivorship.

GBS/CIDP Foundation International invites letters of intent for its Discovery Award. These support researchers who are committed to learning more about Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy and variants.

Researchers of any country are invited to apply for research grants covering ‘basic science’ research that can help support a better understanding of Angelman Syndrome and eventually lead to new treatments tackling the genetic and molecular processes underlying the condition.

The IETF is requesting proposals for grants addressing the etiology and pathogenesis of essential tremor. Concise, clearly written proposals that are hypothesis- driven have the best chance of being funded. Applications should focus on studies achieving one or more of the following goals: 1) A better understanding of the underlying pathophysiology of ET, including independent validation of previous findings. 2) A better understanding of the etiology of ET 3) Development or further validation of animal models of ET

Proposals should address key outstanding questions and have the potential to lead to a challenge or a change in the current paradigm or conventional wisdom and/or lead to a groundbreaking discovery. Preliminary data is not required in the proposal, but the underlying concept, premise or hypothesis must be plausible and testable, and the proposal must be focused with a well-defined goal that is achievable within the timeframe and amount of the award.

Breakthrough T1D invites applications for clinical trials to advance therapies to improve CVD outcomes in T1D.